Professor Mohamed H. Gaber
Address:
Cairo University, Giza, Egypt
Academic Metrics
- h-index: 16
- i10-index: 23
- Total Citations Count: 1702
Research Interests:
Professor Gaber's expertise spans the physical and molecular properties of biological systems and new medical technologies:
- Biophysics And Membrane Permeability
- Nanoparticle And Liposome Drug Delivery Systems
- Cancer Therapeutics And Targeted Delivery
- Nanotoxicology And Cytotoxicity
- Biomedical Engineering And Microwave Effects
Biography:
Biography: Professor Mohamed H. Gaber is a highly cited expert in Biophysics and Nanomedicine, with a focus on advanced drug delivery systems and cancer therapy. His core research investigates the use of liposomes and nanoparticles (e.g., copper, gold, zinc oxide) to improve targeted drug distribution and reduce toxicity. He also studies the effects of physical factors like microwave radiation on biological membranes. His influential work is foundational to the development of novel biomedical technologies and cancer treatments.
Education Details
Professor Gaber's background includes advanced degrees from prominent institutions, focusing on the intersection of physics and medicine:
- PhD: (Inferred from profile).
- M.Sc.: Cairo University.
Professional Background
His professional career has been centered at Cairo University, with significant international collaborations:
- Professor And Head Of Department (Current) - Department Of Biophysics, Cairo University.
- Adjunct/Collaborator: Affiliations often point to research cooperation with institutions like the University of California and Duke University.
Achievements
Professor Gaber has contributed foundational knowledge to the field of targeted drug delivery:
- Co-authored highly cited, seminal papers on the mechanism and use of thermosensitive sterically stabilized liposomes.
- His work on nanoparticles and liposomes provides a strong basis for new cancer therapies.
Grants And Funding
Professor Gaber's research is supported through institutional and research funds, although specific grant names are not publicly detailed:
- Research Funding: Acknowledged funding from AlMaarefa University for a 2023 study.
- Research Focus: Numerous projects concern the development of nanohybrids and novel drug delivery platforms.
Academic Profiles of Professor Mohamed H. Gaber
Explore his academic and professional presence across trusted platforms:
Publications:
Professor Gaber's publications detail the biophysical characteristics and targeted efficacy of liposomal and nanoparticle drug delivery systems.
The list of recent publications of Professor Mohamed H. Gaber is listed below:
- Fahmy, H. M., Ebrahim, N. M., & Gaber, M. H. (2020). In-vitro evaluation of copper/copper oxide nanoparticles cytotoxicity and genotoxicity in normal and cancer lung cell lines. Journal Of Trace Elements In Medicine And Biology, 60, 126481. DOI: 10.1016/j.jtemb.2020.126481.
- Gaber, M., Hany, M., Mokhtar, S., Helmy, M. W., Elkodairy, K. A., & Elzoghby, A. O. (2019). Boronic-targeted albumin-shell oily-core nanocapsules for synergistic aromatase inhibitor/herbal breast cancer therapy. Materials Science And Engineering: C, 105, 110099. DOI: 10.1016/j.msec.2019.110099.
- Gaber, M., Elkodairy, K. A., Sabra, S., Helmy, M. W., & Elzoghby, A. O. (2019). Co-administration of tretinoin enhances the anti-cancer efficacy of etoposide via tumor-targeted green nano-micelles. Colloids And Surfaces B: Biointerfaces, 192, 110997. DOI: 10.1016/j.colsurfb.2020.110997.
- Gaber, M., Arnone, A. A., Vidi, P. A., & Cook, K. L. (2024). The microbiome: a link between obesity and breast cancer risk. Frontiers In Microbiomes, 3. DOI: 10.3389/fmicb.2024.1394719.
- Gaber, M., Wilson, A. S., Millen, A. E., Hovey, K. M., & LaMonte, M. J. (2024). Visceral adiposity in postmenopausal women is associated with a pro-inflammatory gut microbiome and immunogenic metabolic endotoxemia. Microbiome, 12(1), 192. DOI: 10.1186/s40168-024-01516-x.
Last Updated on September 30, 2025